{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:40:10Z","timestamp":1786650010920,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Studies on gadolinium deposition have recently been reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>The objective of this study was to investigate whether there is an increased magnetic resonance signal intensity (SI) of the dentate nucleus (DCN) and quantification of gadolinium (Gd) brain concentrations by inductively coupled plasma-mass spectrometry (ICP-MS) test in rats who had undergone multiple administrations of gadoxetic acid and gadobutrol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Sprague\u2013Dawley rats (24) were equally divided into three groups. Eight animals per group received 20 intravenous injections of gadoxetic acid (0.15 mmol\/kg) and gadobutrol (0.6 mmol\/kg) per injection. MRI was performed at 0, 5, and 20 weeks. Subsequently, all animals were euthanized and their brains were dissected for Gd quantification by ICP-MS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      ICP-MS revealed higher Gd content in cerebellum tissue after administration of gadoxetic acid compared to gadobutrol (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05). The mean Gd concentrations in the cerebellum were 0.48 nmol\/g gadoxetic acid and 0.26 nmol\/g gadobutrol after intravenous administration. No visually evident enhancement was found after administration of gadoxetic acid, gadobutrol, or saline at any time point. The DCN-to-pons SI ratios for gadoxetic acid and gadobutrol were not different from the saline control group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05, saline vs. gadoxetic acid and saline vs. gadobutrol, respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Our results demonstrated that gadolinium concentrations in the cerebellum after intravenous gadoxetic acid administration were higher than for gadobutrol. Multiple administrations of gadoxetic acid disodium are not associated with increased SI in DCN.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ni.ni_776_20","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T16:01:34Z","timestamp":1748016094000},"page":"495-499","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Gadolinium Deposition in the Rat Brain after Repeated Administration of the Liver-Specific Gadolinium-Based Contrast Agent Gadoxetic Acid"],"prefix":"10.4103","volume":"73","author":[{"given":"Kai","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Medical Imaging Center, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yikai","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging Center, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"R1-20260423","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/RMR.0000000000000109","article-title":"Incidence and risk factors for gadolinium-based contrast agent immediate reactions","volume":"25","author":"Costello","year":"2016","journal-title":"Top Magn Reson Imaging"},{"key":"R2-20260423","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12325-015-0275-4","article-title":"25 years of contrast-enhanced MRI: Developments, current challenges and future perspectives","volume":"33","author":"Lohrke","year":"2016","journal-title":"Adv Ther"},{"key":"R3-20260423","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/ndt\/gfk062","article-title":"Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?","volume":"21","author":"Grobner","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R4-20260423","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1148\/radiol.13131669","article-title":"High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: Relationship with increasing cumulative dose of a gadolinium-based contrast material","volume":"270","author":"Kanda","year":"2014","journal-title":"Radiology"},{"key":"R5-20260423","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1148\/radiol.2015142690","article-title":"Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: Evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy","volume":"276","author":"Kanda","year":"2015","journal-title":"Radiology"},{"key":"R6-20260423","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/RLI.0000000000000252","article-title":"Macrocyclic and other non-group 1 gadolinium contrast agents deposit low levels of gadolinium in brain and bone tissue: Preliminary results from 9 patients with normal renal function","volume":"51","author":"Murata","year":"2016","journal-title":"Invest Radiol"},{"key":"R7-20260423","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1148\/radiol.2017161595","article-title":"Gadolinium deposition in human brain tissues after contrast-enhanced MR imaging in adult patients without intracranial abnormalities","volume":"285","author":"McDonald","year":"2017","journal-title":"Radiology"},{"key":"R8-20260423","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/RLI.0000000000000072","article-title":"Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation","volume":"49","author":"Errante","year":"2014","journal-title":"Invest Radiol"},{"key":"R9-20260423","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1007\/s00330-016-4269-7","article-title":"Signal intensity change on unenhanced T1-weighted images in dentate nucleus following gadobenate dimeglumine in patients with and without previous multiple administrations of gadodiamide","volume":"26","author":"Ramalho","year":"2016","journal-title":"Eur Radiol"},{"key":"R10-20260423","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1148\/radiol.14140364","article-title":"High signal intensity in dentate nucleus on unenhanced T1-weighted MR images: Association with linear versus macrocyclic gadolinium chelate administration","volume":"275","author":"Kanda","year":"2015","journal-title":"Radiology"},{"key":"R11-20260423","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/RLI.0000000000000154","article-title":"Gadodiamide and dentate nucleus T1 hyperintensity in patients with meningioma evaluated by multiple follow-up contrast-enhanced magnetic resonance examinations with no systemic interval therapy","volume":"50","author":"Quattrocchi","year":"2015","journal-title":"Invest Radiol"},{"key":"R12-20260423","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1148\/radiol.2015150337","article-title":"Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent","volume":"275","author":"Radbruch","year":"2015","journal-title":"Radiology"},{"key":"R13-20260423","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1148\/radiol.13131669","article-title":"High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: Relationship with increasing cumulative dose of a gadolinium-based contrast material","volume":"270","author":"Kanda","year":"2014","journal-title":"Radiology"},{"key":"R14-20260423","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/RLI.0000000000000308","article-title":"Intraindividual analysis of signal intensity changes in the dentate nucleus after consecutive serial applications of linear and macrocyclic gadolinium-based contrast agents","volume":"51","author":"Radbruch","year":"2016","journal-title":"Invest Radiol"},{"key":"R15-20260423","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00330-015-3873-2","article-title":"Consensus report from the 7th International forum for liver magnetic resonance imaging","volume":"26","author":"Merkle","year":"2016","journal-title":"Eur Radiol"},{"key":"R16-20260423","doi-asserted-by":"crossref","first-page":"498","DOI":"10.2214\/AJR.13.12399","article-title":"Consensus statements from a multidisciplinary expert panel on the utilization and application of a liver-specific MRI contrast agent (gadoxetic acid)","volume":"204","author":"Jhaveri","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"R17-20260423","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1148\/radiol.2015142986","article-title":"Focal nodular hyperplasia and hepatocellular adenoma: Accuracy of gadoxetic acid-enhanced MR imaging--A systematic review","volume":"277","author":"McInnes","year":"2015","journal-title":"Radiology"},{"key":"R18-20260423","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1148\/radiol.11101742","article-title":"Hepatocellular adenoma and focal nodular hyperplasia: Value of gadoxetic acid-enhanced MR imaging in differential diagnosis","volume":"262","author":"Grazioli","year":"2012","journal-title":"Radiology"},{"key":"R19-20260423","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/bjs.9465","article-title":"Randomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases","volume":"101","author":"Zech","year":"2014","journal-title":"Br J Surg"},{"key":"R20-20260423","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00330-014-3144-7","article-title":"Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: A single centre experience","volume":"24","author":"Grieser","year":"2014","journal-title":"Eur Radiol"},{"key":"R21-20260423","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jacr.2015.11.009","article-title":"National institutes of health perspective on reports of gadolinium deposition in the brain","volume":"13","author":"Malayeri","year":"2016","journal-title":"J Am Coll Radiol"},{"key":"R22-20260423","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1148\/radiol.2016162535","article-title":"Is there long-term signal intensity increase in the central nervous system on T1-weighted images after MR imaging with the hepatospecific contrast agent gadoxetic acid? A cross-sectional study in 91 patients","volume":"282","author":"Kahn","year":"2017","journal-title":"Radiology"},{"key":"R23-20260423","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.4103\/0028-3886.246259","article-title":"Gadoxetate disodium, a modern hepatospecific MRI contrast agent: Indirect signs for gadolinium deposition in the brain structures with signal intensity increase after intravenous application","volume":"66","author":"Holesta","year":"2018","journal-title":"Neurol India"},{"key":"R24-20260423","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/RLI.0000000000000360","article-title":"Contrast agent-induced high signal intensity in dentate nucleus on unenhanced T1-weighted images: Comparison of gadodiamide and gadoxetic acid","volume":"52","author":"Ichikawa","year":"2017","journal-title":"Invest Radiol"},{"key":"R25-20260423","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1007\/s00330-017-4810-3","article-title":"Signal intensity change on unenhanced T1-weighted images in dentate nucleus and globus pallidus after multiple administrations of gadoxetate disodium: An intraindividual comparative study","volume":"27","author":"Conte","year":"2017","journal-title":"Eur Radiol"},{"key":"R26-20260423","doi-asserted-by":"crossref","first-page":"765.","DOI":"10.1016\/j.mric.2017.06.007","article-title":"Gadolinium Deposition and Chronic Toxicity","volume":"25","author":"Ramalho","year":"2017","journal-title":"Mag Res Ima Clinics North America"},{"key":"R27-20260423","first-page":"624","article-title":"The laboratory rat: Relating its age with human\u2019s","volume":"4","author":"Sengupta","year":"2013","journal-title":"Int J Prev Med"},{"key":"R28-20260423","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1148\/rg.322105761","article-title":"Intracranial lesions with high signal intensity on T1-weighted MR images: Differential diagnosis","volume":"32","author":"Ginat","year":"2012","journal-title":"Radiographics"},{"key":"R29-20260423","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1148\/radiology.195.3.7754011","article-title":"Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: Safety, pharmacokinetics, and MR imaging","volume":"195","author":"Hamm","year":"1995","journal-title":"Radiology"},{"key":"R30-20260423","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/RLI.0000000000000559","article-title":"Gadolinium presence in the brain after administration of the liver-specific gadolinium-based contrast agent gadoxetate: A systematic comparison to multipurpose agents in rats","volume":"54","author":"Jost","year":"2019","journal-title":"Invest Radiol"},{"key":"R31-20260423","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1148\/radiol.2018180135","article-title":"Long-term excretion of gadolinium-based contrast agents: Linear versus macrocyclic agents in an experimental rat model","volume":"290","author":"Jost","year":"2018","journal-title":"Radiology"}],"container-title":["Neurology India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/NI.NI_776_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:01:02Z","timestamp":1786647662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/NI.NI_776_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ni.ni_776_20","relation":{},"ISSN":["0028-3886","1998-4022"],"issn-type":[{"value":"0028-3886","type":"print"},{"value":"1998-4022","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"2020-06-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}